All Stories

  1. Epstein–Barr virus-induced gene 3 commits human mesenchymal stem cells to differentiate into chondrocytes via endoplasmic reticulum stress sensor

    Article • PLoS ONE, December 2022, PLOS

    Yoshiya Tanaka

  2. A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids

    Article • Modern Rheumatology Case Reports, August 2019, Taylor & Francis

    Yoshiya Tanaka

  3. Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan

    Article • Modern Rheumatology, July 2019, Taylor & Francis

    Yoshiya Tanaka

  4. Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial

    Article • Modern Rheumatology, July 2019, Taylor & Francis

    Yoshiya Tanaka

  5. The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method

    Article • Modern Rheumatology, June 2019, Taylor & Francis

    Shingo Fukuma, Yoshiya Tanaka

  6. Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update

    Article • Expert Review of Clinical Immunology, April 2019, Taylor & Francis

    Yoshiya Tanaka

  7. Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study

    Article • Modern Rheumatology, February 2019, Taylor & Francis

    Yoshiya Tanaka

  8. The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects

    Article • Modern Rheumatology Case Reports, January 2019, Taylor & Francis

    Yoshiya Tanaka

  9. Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data

    Article • Modern Rheumatology, November 2018, Taylor & Francis

    Shoko Arai, Yoshiya Tanaka

  10. Immunophenotype involved in IgG4-related disease

    Article • Modern Rheumatology, October 2018, Taylor & Francis

    Yoshiya Tanaka

  11. Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan

    Article • Modern Rheumatology, July 2018, Taylor & Francis

    Yoshiya Tanaka

  12. The role of nailfold videocapillaroscopy in patients with systemic sclerosis

    Article • Immunological Medicine, July 2018, Taylor & Francis

    Yoshiya Tanaka

  13. A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab

    Article • Lupus, March 2018, SAGE Publications

    Yoshiya Tanaka

  14. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus

    Article • Lupus, January 2018, SAGE Publications

    Yoshiya Tanaka

  15. Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120

    Article • Modern Rheumatology, December 2017, Taylor & Francis

    Yoshiya Tanaka

  16. RANKL: A therapeutic target for bone destruction in rheumatoid arthritis

    Article • Modern Rheumatology, September 2017, Taylor & Francis

    Dr. Sakae Tanaka, Yoshiya Tanaka

  17. Twenty-four-hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring

    Article • Journal of Diabetes Investigation, May 2017, Wiley

    Yoshiya Tanaka

  18. B-cell subsets, signaling and their roles in secretion of autoantibodies

    Article • Lupus, May 2016, SAGE Publications

    Yoshiya Tanaka

  19. Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report

    Article • Endocrinology Diabetes and Metabolism Case Reports, May 2016, Bioscientifica

    Yoshiya Tanaka

  20. A multi-biomarker disease activity score for monitoring rheumatoid arthritis

    Article • Current Biomarker Findings, October 2015, Taylor & Francis

    Yoshiya Tanaka

  21. Combination therapy for early rheumatoid arthritis: a treatment holiday perspective

    Article • Expert Review of Clinical Pharmacology, November 2014, Taylor & Francis

    Yoshiya Tanaka